NuGen Medical Devices Inc.
NGMD.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -254.19% | 199.29% | 116.80% | -212.17% | 48.70% |
| Total Depreciation and Amortization | 7.83% | -2.83% | -0.88% | -2.40% | -8.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 159.78% | -74.02% | -250.17% | 210.03% | -30.27% |
| Change in Net Operating Assets | 152.83% | 91.88% | -298.18% | 253.19% | -34.35% |
| Cash from Operations | 10.12% | 71.37% | -204.49% | -317.79% | 74.01% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00% | 0.00% | 0.00% |
| Cash from Investing | -- | -- | -2,466.67% | 0.00% | 0.00% |
| Total Debt Issued | -- | -- | -200.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 66.35% |
| Issuance of Common Stock | -100.00% | -99.42% | 15,907.69% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -85.41% | -96.08% | 144,796.08% | -100.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.25% | 69.13% | -125.48% | 4,245.56% | -214.34% |